Tamoxifen Gel Equal to Oral Tx in DCIS
(MedPage Today) -- A topical formulation of tamoxifen matched oral therapy for antiproliferative activity in ductal carcinoma in situ with fewer potentially troublesome effects on endocrine and coagulation parameters, a small randomized trial showed.
Source: MedPage Today Endocrinology - Category: Endocrinology Source Type: news
More News: Cancer & Oncology | Carcinoma | Carcinoma in Situ | DCIS (Ductal Carcinoma in Situ) | Ductal Carcinoma | Endocrinology | Oral Cancer | Tamoxifen